Analyzing...
Loading company...
Fortis Healthcare Ltd. engages in the provision of healthcare delivery services through its subsidiaries. The company is headquartered in Gurgaon, Haryana and currently employs 2,975 full-time employees. The company went IPO on 2007-05-09. The firm is primarily engaged in the business of healthcare services. The company operates through two segments: Healthcare and Diagnostics. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics and ophthalmology, among others. The company manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics and day care specialty facilities. The company has approximately 36 healthcare facilities, including projects under development, 4000 operational beds and over 400 diagnostics centers. The company operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Healthstaff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.
No significant concerns identified
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹9,128 Cr service revenue.
Employee costs at 14.2% of revenue — primary cost driver.
“we still maintain the full year addition of about 400, 500 beds?”
“Excluding one offs, an operating EBITDA margin stood at 24% in '25.”
“we are expecting around five, six percent ARPA growth, even in the second half.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 10.5%▲ | 9.0% |
| ROCE | 12.0%▲ | 10.4% |
| Net Margin | 11.3%▲ | 8.5% |
| EBITDA Margin | 23.0%▲ | 20.6% |
| Debt To Equity | 0.29x▲ | 0.16x |
| Rev Growth 3yr | 13.0%▼ | 14.4% |
| EPS Growth 3yr | 20.9%▲ | 9.9% |
| Employee Cost Ratio | 14.20x | - |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹9,128 Cr +17.3% | ₹7,783 Cr +12.9% | ₹6,893 Cr +9.5% | ₹6,298 Cr +10.1% | ₹5,718 Cr +41.9% | ₹4,030 Cr -13.0% | ₹4,632 Cr +3.6% | ₹4,469 Cr |
| Other Income | ₹51 Cr -24.3% | ₹67 Cr +75.0% | ₹38 Cr -38.0% | ₹62 Cr +125.7% | ₹27 Cr -41.3% | ₹47 Cr -11.6% | ₹53 Cr -43.0% | ₹92 Cr |
| Total Income | ₹9,179 Cr +16.9% | ₹7,850 Cr +13.3% | ₹6,931 Cr +9.0% | ₹6,359 Cr +10.7% | ₹5,745 Cr +40.9% | ₹4,077 Cr -13.0% | ₹4,685 Cr +2.7% | ₹4,562 Cr |
| COGS | ₹2,089 Cr +14.1% | ₹1,830 Cr +13.1% | ₹1,619 Cr +11.3% | ₹1,455 Cr +7.2% | ₹1,357 Cr +39.1% | ₹976 Cr +1.3% | ₹964 Cr +3.8% | ₹928 Cr |
| ₹7,807 Cr +15.4% | ₹6,765 Cr +10.9% | ₹6,099 Cr +8.1% | ₹5,641 Cr +10.7% | ₹5,096 Cr +24.8% | ₹4,082 Cr -9.7% | ₹4,520 Cr -6.1% | ₹4,814 Cr | |
| Profit Before Tax | ₹1,350 Cr +35.6% | ₹996 Cr +17.3% | ₹848 Cr +7.2% | ₹792 Cr -17.8% | ₹964 Cr ↑ Recovery | (₹4 Cr) ↓ Decline | ₹227 Cr ↑ Recovery | (₹475 Cr) |
| Exceptional Items | (₹22 Cr) +75.1% | (₹89 Cr) ↓ Decline | ₹16 Cr -78.2% | ₹74 Cr -76.6% | ₹315 Cr | ₹1 Cr -98.0% | ₹62 Cr ↑ Recovery | (₹222 Cr) |
| ₹302 Cr +52.6% | ₹198 Cr -7.1% | ₹213 Cr +17.7% | ₹181 Cr -8.7% | ₹198 Cr +98.9% | ₹99 Cr -32.7% | ₹148 Cr +30.2% | ₹114 Cr | |
| Net Profit | ₹1,064 Cr +31.5% | ₹809 Cr +25.4% | ₹645 Cr +1.9% | ₹633 Cr -19.9% | ₹790 Cr ↑ Recovery | (₹56 Cr) ↓ Decline | ₹91 Cr ↑ Recovery | (₹224 Cr) |
| Profit (Owners) | ₹1,042 Cr +34.6% | ₹774 Cr +29.3% | ₹599 Cr +1.7% | ₹589 Cr +6.1% | ₹555 Cr ↑ Recovery | (₹110 Cr) ↓ Decline | ₹58 Cr ↑ Recovery | (₹224 Cr) |
| Minority Interest | ₹22 Cr -36.3% | ₹35 Cr -24.1% | ₹46 Cr +4.7% | ₹44 Cr -81.2% | ₹235 Cr +338.2% | ₹54 Cr +59.7% | ₹34 Cr | ₹0.00 Cr |
| Other Comprehensive Income | ₹13 Cr ↑ Recovery | (₹4 Cr) ↓ Decline | ₹2 Cr ↑ Recovery | (₹8 Cr) +83.1% | (₹47 Cr) ↓ Decline | ₹10 Cr | ₹0.11 Cr ↑ Recovery | (₹45 Cr) |
| EPS | ₹13.80 | ₹10.26 | ₹7.93 | ₹7.80 | ₹7.35 | (₹1.45) | ₹0.77 | (₹2.96) |
| Diluted Shares | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr |
| Profit Or Loss Of Associates | ₹16 Cr +41.9% | ₹12 Cr +21.1% | ₹10 Cr -56.5% | ₹22 Cr -9.6% | ₹24 Cr -49.2% | ₹48 Cr +291.1% | ₹12 Cr -96.7% | ₹364 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Fortis Healthcare Limited has informed the Exchange about Schedule of meet
Fortis Healthcare Limited has informed the Exchange about Schedule of meet
Fortis Healthcare Limited has informed the Exchange regarding 'Intimation on Tax Deduction at Source (TDS) / withholding tax on Dividend'.
Fortis Healthcare Limited has informed the Exchange regarding a press release dated July 20, 2026, titled "Agilus Diagnostics Limited(Subsidiary of the Company) Appoints Vijender Singh as Managing Dir...
Fortis Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Fortis Healthcare Limited has informed the Exchange regarding 'closure ofRegister of Members'.
Fortis Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 24-Jul-2026.
Fortis Healthcare Limited has informed the Exchange about General Updates
Fortis Healthcare Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report ( BRSR )'.
Fortis Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026
Fortis Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quater ended June 30, 2026.
Fortis Healthcare Limited has informed the Exchange regarding Appointment of Dr. Ashutosh Raghuvanshi as Managing Director & CEO of the company w.e.f. March 19, 2027.
Fortis Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 08, 2026 regarding re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Ma...
Fortis Healthcare Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements)Regulations 2015 (SEBI Listing Regulations)-Income ...
Fortis Healthcare Limited has informed the Exchange regarding 'Special Window for Re-lodgement of Transfer Requests of Physical Shares'.